تحميل...
Prolongation of tumor volume doubling time (midDT) is associated with improvement in disease specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapy.
PURPOSE: To assess molecular targeted therapy (MTT) ‘s ability to affect tumor volume doubling time (TVDT) and disease specific survival (DSS) in patients presenting with lung metastasis from radioactive iodine refractory progressive thyroid cancer. METHODS: In this retrospective study, we examined...
محفوظ في:
| الحاوية / القاعدة: | Clin Endocrinol (Oxf) |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2019
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6761925/ https://ncbi.nlm.nih.gov/pubmed/30706513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13941 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|